Severe surgical infection refers to infection after surgical treatment or surgical operation, accounting for approximately 30% of surgical diseases. This type of infection can cause extensive inflammation and tissue injury and reduce success rate of surgical treatments. Immune defense plays an important role in antiinfection treatment of hosts. Infection immunity is a series of physiological defense mechanisms for recognition of immune system and removal of pathogens. As for severe surgical infection, immunotherapy becomes an important and promising therapy for severe surgical infection. This study summarizes recent progresses achieved in immunization and immunotherapy of surgical infection.
Immune mechanism of severe surgical infection
Immunological characteristics and changes in severe surgical infection
Infectious immune responses include innate immunity and adaptive immunity. Innate immunity includes barrier immunity, complement replacement pathway, phagocytic cells, cytokines, and natural killer (NK) cells. Adaptive immunity includes CD4+ cell functional differentiation, cellular immune response, humoral immune response, and immune memory. Immune and adaptive immunity against pathogens feature the following characteristics: (1) inherent immune f unctions in preinfection, adaptive immune response functions in late infection; these functions promote and complement each other; (2) different antiinfection i m mu ne mecha n isms i nduced by d i f ferent t y pes of pathogens; (3) pathogens can escape and resist immune response, especially for inherent immune response with poor specificity; and (4) injury and disease caused by infection not only result from pathogens but also from inappropriate immune response of the body itself.
Followed by severe surgical infection, adaptive immune response changes, mainly affecting T helper (Th) cells and temporarily inhibiting Thl-type cytokine-mediated pathway but not affecting Th2-type cytokine reaction, leading to imbalance of Thl/Th2 ratio of major surgeries. Levels of antiinflammatory cytokines significantly increase in severe surgical infections. T cells shift from Th1 to Th2, resulting in immune disorders or immunosuppression. Surgical infection can cause systemic inf lammatory response and severe immunosuppression, leading to sepsis. Sepsis can also lead to immunosuppression, which is characterized by reduction of mononuclear cells expressing human leukocyte antigen (HLA), damaged capability of mononuclear cells that stimulate T cells, decrease in host antibacterial virus-related Th1 cytokines, and increase in host's immunosuppressionrelated T h 2 c y tok i nes a nd reg u lator y T-cel l fac tor [interleukin (IL)-4 and IL-10]. Sepsis is associated with significant intrinsic and adaptive immune dysfunctions. Immune imbalance is mainly manifested as dysfunctions of cellular immune and immunoregulatory cells, leading to immune paralysis. Su rg ic a l t rau m a c a n i nduce t he i m mu ne s y s tem to rapid ly produce proi n f la m mator y c y tok i nes a nd other inf lammatory mediators. Antiinf lammatory and proinf lammatory responses concurrently occur in the body. When proinf lammatory response is more significant than antiinf lammatory response, systemic inf lammatory response syndrome (SIRS) and inf lammatory mediator cascade occur. Initiation of reticuloendothelial system may result in increased telangiectasia and permeability, water accumulation of the third gap, and severe shock. Followed by initial inf lammatory response, compensatory resistance of antiinf lammator y response is generated. When antiinf lammatory response is more significant than proinflammatory response, compensatory antiinflammatory response syndrome (CARS) occurs, and antiinf lammatory cytokines exhibit strong immunosuppressive effects. At this point, the body's susceptibility to pathogenic microorganisms increases and becomes prone to causing severe postoperative infection complications. SIRS and CARS represent immune hyperactivity or inhibition caused by breakdown of immune self-steady state. Uncontrolled inf lammatory response eventually leads to multiple organ dysfunctions.
Influence of surgical trauma on immune system

Immunodeficiency support for severe surgical infection
Immune nutrition Surgical nutrition support can improve organic metabolism and correct negative nitrogen balance, which is conducive to tissue repair, organ maintenance, and patient rehabilitation. Surgical nutrition support can also provide material basis for synthesis of immune proteins, which are conducive to generation of a variety of immune factors and media. Some nutrients, such as ammonia acid, glutamine, and fish oil, may be directly involved in immune function regulation. Nutritional support with glutamine can maintain intestinal barrier function and regulate immune functions. The intestinal tract is also an important immune organ, covering 60% of lymphocytes. Intestinal barrier dysfunction can lead to intestinal endotoxin and bacterial translocation and then generate SIRS, sepsis, and multiple organ dysfunction syndrome. Intestinal barrier functions include intestinal mucosal mechanical barrier, immune barrier of intestinal endocrine IgA lymphatic system, chemical barrier composed by gastrointestinal digestive juice, and biological barrier composed by intestinal normal bacteria.
Application of intestinal immune nutrients
Amino acids, antioxidant vitamins, minerals, long chain n −3 fatty acids, and nucleotides can regulate and improve immune functions. Enteral immune nutrition mixtures include arginine, long chain n−3 fatty acids, and nucleotides, which are widely used among operative patients and seriously ill patients. Xiaohua et al. [1] randomly divided 96 cases of gastric cancer patients into enteral immunodeficiency group (study group) and conventional enteral nutrition group (control group). These researchers provided equal nitrogen and equal-calorie enteral nutrition support to patients from second day to eighth day after operation and tested relevant indicators from the first day to ninth day. Nitrogen was also tested, and its balance was calculated within 24 h of drug administration. Results showed significantly higher prealbumin, IgA, CD4, and CD4/CD8 in the study group than the control group. IL-6 and tumor necrosis factor (TNF)-α were significantly lower than those in the control group, proving that enteral immune nutrition can reduce postoperative inf lammator y response and improve immune functions of patients with gastric cancer. Okamoto et al. [2] divided 60 patients with gastric cancer into two groups. One group was provided with arginine and omega-3 fatty acids, and another group was served with standard diet for seven days before operation. Results showed that postoperative infection complication rate of immunodeficiency group reached 6%, which is significantly lower than the 28% observed in conventional diet group. This result is similar to that in duration of SIRS. From the first day to seventh day before operation, CD4+ T cells of immunodeficiency group were significantly higher than those in the conventional diet group. CD4+ T cells may play an important role in postoperative immunoregulation and inflammatory response in patients undergoing gastrectomy. Cerantola et al. [3] conducted a metaanalysis on perioperative immunological effects on gastrointestinal surgery patients, including 2730 patients in 21 randomized controlled trials. Results showed that providing enteral immunonutrition to gastrointestinal surgery patients in perioperative period can reduce postoperative infection morbidity and hospitalization time but exhibits no effect on mortality. Thus, routine application of enteral immunonutrition is recommended to such patients. Zheng et al. [4] carried out a metaanalysis a mong 12 69 gast roi ntest i na l su rger y pat ients i n 13 randomized controlled trials. Their results showed that two or more immune nutrients (including arginine, glutamine, and omega-3 fatty acids) can reduce postoperative infection morbidity and hospitalization time. Immune functions can be improved by increasing total number of lymphocytes, CD4+T cells, and IgG level and decreasing IL-6 level.
Intravenous glutamine can increase the proportion of CD4+ T cells and CD8+ T cells in the blood, improve intestinal barrier f unction, and reduce occurrence of intestinal bacterial translocation in patients with potential infection. Early studies indicated that glutamine applied among intensive care unit (ICU) patients can reduce mortality compared with parenteral nutrition (PN). Clinical effects of glutamine are related to expression of mononuclear cell HLA D-related (HLA-DR) and production of IFN-γ of T cells. Some clinical reports showed that critically ill patients lack glutamine. Decreased glutamine level in the blood exhibits certain influence on immune function, organ function, and prognosis of patients. Application of parenteral glutamine also poses significant effects. Administering parenteral glutamine in postoperative patients can enhance lymphocyte proliferation in the blood. Parenteral glutamine was provided to abdominal surger y patients for 48 h. Expression of HLA-DR of mononuclear cells showed good level of maintenance. The following are recommendations from the US enteral nutrition mixture application regarding HLA-DR: (1) may benefit patients with gastrointestinal surgery, burns, and penetrating torso trauma; (2) may benefit some patients with major surgeries, severe head injuries, burns>30%, and ventilation-dependent nonseptic ICU patients; and (3) may feature no remarkable benefits for ICU patients who are monitored generally and can restore oral intake within five days.
Application of fat emulsion
Fat emulsion is an important component of PN. Clinically applied fat emulsions mainly comprise soybean oil and/or coconut oil and palm oil. n−6 Polyunsaturated fatty acid (n− 6 PUFA) or saturated fatty acid (SFA) feature high contents and easily form peroxidation products, resulting in tissue injury and depletion of natural antioxidant storage. In olive oil fat emulsion, high-content PUFA and SFA are replaced by monounsaturated fatty acid (MUFA). Oleic acid (n−9 MUFA) is the main fatty acid contained in olive oil. Xinying et al. [5] randomly divided 40 critically ill patients into experimental (n=19) and control (n=21) groups and provided them with equal nitrogen and equal-heat PN for seven days. Patients in the control group were treated with long-chain fat emulsion, whereas those in experimental group were treated with olive oil fat emulsion. Effects of PN containing different fatty acids on oxidative stress and inf lammatory responses were observed in critically ill patients. Results showed that olive oil fat emulsion reduced excessive inf lammatory responses of critically ill patients and oxidative stress injury.
Some clinical studies indicated that fat emulsions containing fish oil can be used in postoperative patients to reduce generation of inf lammatory factors (IL-4, TNF-α, and IL-6) and protect immune functions (e.g., monocyteexpressed HLA-DR and IFN-γ). Use of fish oil during surgery can reduce the need for mechanical ventilation, reduce rate of reentry in ICU, decrease mortality, and shorten length of hospitalization. Antiinflammatory effects of fish oil on sepsis patients include reduction in white blood cell count, plasma C-reactive protein level, and inf lammatory factors generated by endotoxin-stimulated mononuclear cells; increase in stimulated neutrophils generates IL-B5. Marik et al. [6] performed a metaanalysis among 21 randomized prospective controlled trials involving 1918 patients and concluded that preoperative administration of high-risk patients with major surgery administered with arginine and fish oil immunoregulation diet can reduce incidence of postoperative-acquired infection, wound complications, and hospitalization time.
Other immunological nutrients
A ntiox idant micronutrients (including zinc, copper, selenium, vitamin E, vitamin C, and N-acetylcysteine) and arginine can increase immune nutrition and improve immune functions and are also gradually applied in clinical treatments.
Immunosuppressive treatment of severe surgical infection
Thymosin α1 is a protein peptide hormone generated by the thy mus, play ing an important role in immune response, neuroendocrine regulation, and gene expression. This protein can induce and promote differentiation and maturation of thymocytes, promote transformation of bone marrow stem cells into T lymph (TNF-α), and further differentiate into T cell subsets with different functions and increase generation of CD4+ and CD8+T. Thymosin α1 can also regulate levels of TNF-α, IL-6, IL-10, and other cytokines in severely infected patients, reduce inflammatory responses, and improve immune function of patients. As an immune regulator, thymosin α1 can delay increase in levels of TNF-α, IL-6, and other proinflammatory cytokines when adjusting patients' immune systems, reducing inflammatory response induced by inflammatory mediators, and increasing level of antiinf lammatory factor IL-10. Thymosin α1 can also promote the balance between antiinf lammatory and proinf lammatory factors. Xiaolei randomly divided 45 patients with severe surgical infection into treatment and control groups. Results showed that level of IL-10 increased in the treatment group (using thymosin α1, such as zadaxin). The control group showed significantly high levels of TNF-α and IL-6.
Continuous blood purif ication (CBP) can regulate immune function disorders, remove some inf lammatory factors, improve functions of monocytes and endothelial cells, rebuild immune state of organic immunity, and treat and control serious infections. Jieshou reported 136 cases with severe abdominal infection treated by CBP. Results showed that curative rate of CBP reached 94.8%. According to clinical studies, combined CBP and thymosin α1 can treat severe sepsis and improve cellular immune function, organic function recovery, and prognosis [9] .
Ulinastatin is a protease inhibitor that can inhibit multiple enzymes and improve immune function disorder caused by surgical stimuli and abnormal protein metabolism. Ulinastatin can also prevent organ and cell damage caused by surgical stimuli and improve circulation status during shock.
Colony stimulating factor (CSF) is a small molecule polypeptide that regulates replication, proliferation, and differentiation of hematopoietic stem cells. Granulocyte CSF (G-CSF) and granulocyte-macrophage CSF (GM-CSF) exhibit positive effects on neutrophils, monocytes, macrophages, and lymphocy tes. G-CSF and GM-CSF can delay apoptosis of neutrophils, upgrade expressions of CD11b and CD14 molecules, and enhance adhesion chemotaxis and phagocytosis. Clinical studies demonstrated that G-CSF and GM-CSF can improve mononuclear cell function of severely postoperative infected patients, increase expressions of TNF-α and HLA-DR, increase the number of lymphocytes, regulate T cell proliferation and differentiation, enhance immune activity of Th1, and reverse low response of adaptive immunity. Thus, these factors can be used to treat granulocyte reduction and surgical infection. Orozco et al. [10] reported 58 cases of nontraumatic abdominal sepsis patients treated by moraxastine (GM-CSF) and antibiotics. Results showed reduced infection complications, hospitalization time, and costs.
Problems and prospects
Recently, more in-depth studies were performed on immune mechanism and immunotherapy of surgical infection, and several new results were achieved, providing additional immunological theoretical bases and immune therapy means for controlling severe surgical infection. However, few research specifically focused on effects of surgical trauma and infection on immune system. Issues arise from studies of effects and application of immunotherapy. The role of immunomodulator still lacks full clinical evidence. Future surgical immunology research will achieve more feasible results. With development of antibiotics and perioperative ster i le technolog y, ser ious surg ica l infection can be controlled effectively.
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